| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4788400
Max Phase: Preclinical
Molecular Formula: C37H51NO3
Molecular Weight: 557.82
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: C=CCCCCCCCCN(CCCCCCCCC=C)c1ccc2c(c1)C(=O)/C(=C/c1ccc(O)c(OC)c1)C2
Standard InChI: InChI=1S/C37H51NO3/c1-4-6-8-10-12-14-16-18-24-38(25-19-17-15-13-11-9-7-5-2)33-22-21-31-28-32(37(40)34(31)29-33)26-30-20-23-35(39)36(27-30)41-3/h4-5,20-23,26-27,29,39H,1-2,6-19,24-25,28H2,3H3/b32-26+
Standard InChI Key: OLQKMTQHBWMMKL-HMZBKAONSA-N
Associated Targets(non-human)
Pancreatic triacylglycerol lipase 476 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 557.82 | Molecular Weight (Monoisotopic): 557.3869 | AlogP: 9.86 | #Rotatable Bonds: 21 |
| Polar Surface Area: 49.77 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
| #RO5 Violations: 2 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
| CX Acidic pKa: 9.48 | CX Basic pKa: 4.96 | CX LogP: 10.91 | CX LogD: 10.91 |
| Aromatic Rings: 2 | Heavy Atoms: 41 | QED Weighted: 0.09 | Np Likeness Score: 0.20 |
References
| 1. Huo PC,Hu Q,Shu S,Zhou QH,He RJ,Hou J,Guan XQ,Tu DZ,Hou XD,Liu P,Zhang N,Liu ZG,Ge GB. (2021) Design, synthesis and biological evaluation of novel chalcone-like compounds as potent and reversible pancreatic lipase inhibitors., 29 [PMID:33214035] [10.1016/j.bmc.2020.115853] |
Source
Source(1):